Egon Zehnder
Suche
Select region
Close filter

Ash Kolady

Kontakt

+1 972 728 5978

Connect With Me

Ash Kolady offers deep Industrial Segment expertise in automotive, machinery, distribution, and industrial services. He works across functions with a particular focus on placing executives in general management, strategy, finance and commercial leadership roles. Ash is active across Egon Zehnder’s CFO, CEO, Automotive & Transportation Equipment, and Machinery & Industrial Technology practices.

I believe in a better world through better leadership. My work gives me a unique window on how the best organizations attract and develop talent and what distinguishes outstanding leaders from the rest.

Prior to joining Egon Zehnder, Ash was the Chief Operating Officer of AZZ Inc., a publicly traded energy and infrastructure company. While that firm’s Vice President for Corporate Development, he was responsible for corporate strategy and led a number of successful acquisitions. Earlier, Ash served in various operational, marketing, and business development roles at Eaton Corporation. He launched his career at General Motors as an engineer.

Ash earned a BTech in mechanical engineering from the University of Kerala, in India, an MEng in operations research & industrial engineering from Cornell University, and an MBA from Michigan State University.

Meine Schwerpunkte

Kontakt
E-Mail an Ash Kolady
Browse all
Interviews, Artikel und Studien

Related Experts Around the Globe

Katharina von Frankenberg

Katharina von Frankenberg

Hamburg

Katharina von Frankenberg arbeitet im Bereich Private Equity und ist Teil der Praxisgruppen Industrial und CFO von Egon Zehnder. Mehr erfahren

Manuel de Miranda

Manuel de Miranda

Lisbon

Manuel spent seven years in New York before founding our Washington DC office where, where he continues to serve as a trusted advisor to… Mehr erfahren

Gaëlle Boix

Gaëlle Boix

Geneva

Gaëlle Boix is based in Geneva and coleads the firm’s European Health Practice. She focuses on health care and serves clients across pharma, generics… Mehr erfahren

Back to top